HomePGEN • NASDAQ
add
Precigen Inc
Previous close
$1.44
Day range
$1.36 - $1.43
Year range
$0.65 - $2.17
Market cap
407.25M USD
Avg Volume
1.41M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.19M | -3.09% |
Operating expense | -30.31M | -19.55% |
Net income | -19.73M | 40.32% |
Net profit margin | -1.66K | 38.42% |
Earnings per share | -0.03 | 62.43% |
EBITDA | -22.08M | -1.38% |
Effective tax rate | 0.44% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 97.91M | 55.77% |
Total assets | 145.27M | -3.82% |
Total liabilities | 106.75M | 228.02% |
Total equity | 38.51M | — |
Shares outstanding | 294.04M | — |
Price to book | 11.08 | — |
Return on assets | -49.70% | — |
Return on capital | -108.13% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -19.73M | 40.32% |
Cash from operations | -8.24M | 47.72% |
Cash from investing | -65.37M | -591.74% |
Cash from financing | 78.40M | — |
Net change in cash | 4.79M | 292.68% |
Free cash flow | -10.00M | -19.76% |
About
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
Founded
May 21, 1998
Website
Employees
143
